Stock listing

Tempest Therapeutics, Inc.

Selected listing: A41556 · LS · EUR · DE

Tempest Therapeutics, Inc. (Lang & Schwarz: A41556), Health Technology. Latest release Sep 23, 2026: Tempest Appoints Global Finance Leader Nancy Freda-Smith…

A41556:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A41556
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Tempest Therapeutics, Inc.

Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors

September 23, 2026

Tempest Therapeutics Announces Up to $7.5 Million Private Placement

September 11, 2026

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 8, 2026

Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026

Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T

July 21, 2026

All Tempest Therapeutics, Inc. news →

Research Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc. company profile

View the public company page for Tempest Therapeutics, Inc. on 6ix.

Tempest Therapeutics, Inc. news

Read company news and market updates connected to Tempest Therapeutics, Inc..

Tempest Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Tempest Therapeutics, Inc..